BCL6 and breast carcinoma: Furthermore, metaTF provides a superior characterization of the functional identity of breast cancer epithelial cells, and identifies a novel subset of neural‐regulated T cells within the tumor immune microenvironment, which potentially activates BCL6 in response to neural‐related signals.